$STZ

CONSTELLATION BRANDS, INC.

46
21
30

No SEC Form 4 filings for $STZ in the last 30 days.

See all $STZ insider activity →
Low

Stock Market Today, Oct. 7: Markets Edge Lower as Treasury Yields Surge

U.S. stock indexes fell slightly, with the S&P 500 down 0.23% to 7,801. Caterpillar (CAT) dropped 5.7% after a broker downgrade, while Intel (INTC) and Nvidia (NVDA) gained on project news. Gold prices fell 1.34% to $4,130.80, and the 10-Year Treasury yield declined to 5.27%.

Coke's prebiotic soda, Starbucks-Chipotle tie-up, Modelo sales: Food roundup

Coca-Cola (KO) is launching a prebiotic fiber-infused soda in a pilot program. Chipotle (CMG) is reportedly exploring takeover options, with speculation about a potential tie-up with Starbucks (SBUX). Constellation Brands (STZ) beat earnings expectations, with beer sales up 5%, but Modelo Especial and Corona Extra sales declined. The company acquired Spiked for up to $353 million.

STZ sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 97 news stories mentioning STZ (CONSTELLATION BRANDS, INC.). Coverage has skewed bullish: 46 bullish, 21 neutral, and 30 bearish.

Recent STZ coverage spans earnings, market movers and mergers & acquisitions.

What's driving STZ

AlphAI scores every news story that mentions STZ with an AI model for sentiment and relevance, and aggregates insider trades from CONSTELLATION BRANDS, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $STZ

Score
$KOMedAI 8/10

Coke's prebiotic soda, Starbucks-Chipotle tie-up, Modelo sales: Food roundup

Coca-Cola (KO) is launching a prebiotic fiber-infused soda in a pilot program. Chipotle (CMG) is reportedly exploring takeover options, with speculation about a potential tie-up with Starbucks (SBUX). Constellation Brands (STZ) beat earnings expectations, with beer sales up 5%, but Modelo Especial and Corona Extra sales declined. The company acquired Spiked for up to $353 million.

$STZMedAI 8/10

Corona and Modelo Are Shrinking While Pacifico and Victoria Are Booming. Here's What That Means for Constellation Brands Stock.

Constellation Brands (STZ) reported Q2 revenue of $2.63B, beating estimates. Beer shipments rose 5.5%, but depletions fell 0.6%. Corona and Modelo saw depletion declines, while Pacifico and Victoria grew 19% and 15%, respectively. EPS was $3.74, ahead of consensus. Full-year guidance was reaffirmed. The company gained 0.8% market share, according to Circana.

$STZMedAI 8/10

Goldman Sachs lowers Constellation Brands stock price target on weaker second-half outlook

Goldman Sachs cut its price target for Constellation Brands (STZ) to $155 from $180, maintaining a Buy rating. The stock is currently trading at $118.20 with a 3.56% dividend yield. Q2 earnings per share of $3.74 beat estimates, driven by strong beer shipments and better-than-expected margins. Management maintained fiscal 2027 guidance, expecting a second-half decline in beer net sales and EPS. Despite beating estimates, the stock showed a downward trend in premarket trading.

$STZHighAI 8/10

Constellation Brands Beat Wall Street, but Beer Drinkers Aren’t Showing Up

Constellation Brands reported adjusted earnings of $3.74 per share, beating estimates, with net sales up 6% YoY to $2.63B. However, beer depletions fell 0.6%, with Modelo and Corona Extra declining. Shares initially dropped but later rose 2% after CEO Nick Fink revised EPS guidance to $11.20-$11.90. The company is diversifying with the $75M acquisition of SpikedAde.

$STZMedAI 8/10

Modelo owner Constellation is getting creative to bring back beer drinkers as overall demand weakens

Constellation Brands reported fiscal Q2 earnings of $3.74 per share on $2.63B revenue, beating estimates. Beer revenue rose 5% to $2.47B, but depletions declined slightly. The company is focusing on special occasions and diversification to drive sales amid consumer caution. CEO Nicholas Fink noted September depletions are improving. Analysts attribute challenges to elevated gas prices, with a $209 price target on the stock.

$STZLow

Jim Cramer: 'there are a lot of issues' with Constellation Brands stock

Constellation Brands (STZ) reported Q2 earnings of $3.74 per share on $2.63 billion sales, beating estimates but keeping guidance unchanged. Shares initially fell but recovered after management indicated potential for top-end fiscal 2027 results. Jim Cramer remains bearish, citing challenges like GLP-1 treatments and beer margin pressures. STZ is acquiring SpikedAde for up to $353 million, raising concerns about balance sheet strain. Analysts rate STZ overweight with a mean price target of $160.

$STZMedAI 8/10

Morgan Stanley flags 2H margin pressure after Constellation Brands’ Q2 beat

Constellation Brands STZ reported Q2 EPS of $3.74, beating Morgan Stanley's $3.57 estimate. Sales, gross, and operating profit also exceeded expectations. Beer shipments rose 5.5%, but depletions fell 0.6%. Modelo Especial and Corona Extra depletions declined 2% and 5%, respectively. Morgan Stanley notes potential margin pressure in 2H, maintaining a $158 price target and equal-weight rating.

Related tickers